Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells

被引:496
作者
Fain, John N. [1 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Coll Med, Memphis, TN 38163 USA
来源
INTERLEUKINS | 2006年 / 74卷
关键词
D O I
10.1016/S0083-6729(06)74018-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The white adipose tissue, especially of humans, is now recognized as the central player in the mild inflammatory state that is characteristic of obesity. The question is how the increased accumulation of lipid seen in obesity causes an inflammatory state and how this is linked to the hypertension and type 2 diabetes that accompanies obesity. Once it was thought that adipose tissue was primarily a reservoir for excess calories that were stored in the adipocytes as triacylglycerols. In times of caloric deprivation these stored lipids were mobilized as free fatty acids and the insulin resistance of obesity was attributed to free fatty acids. It is now clear that in humans the expansion of adipose tissue seen in obesity results in more blood vessels, more connective tissue fibroblasts, and especially more macrophages. There is an enhanced secretion of some interleukins and inflammatory cytokines in adipose tissue of the obese as well as increased circulating levels of many cytokines. The central theme of this chapter is that human adipose tissue is a potent source of inflammatory interleukins plus other cytokines and that the majority of this release is due to the nonfat cells in the adipose tissue except for leptin and adiponectin that are primarily secreted by adipocytes. Human adipocytes secrete at least as much plasminogen activator inhibitor-1 (PAI-1), MCP-1,(1) interleukin-8 (IL-8), and IL-6 in vitro as they do leptin but the nonfat cells of adipose tissue secrete even more of these proteins. The secretion of leptin, on the other hand, by the nonfat cells is negligible. The amount of serum amyloid A proteins 1 & 2 (SAA I & 2), haptoglobin, nerve growth factor (NGF), macrophage migration inhibitory factor (MIF), and PAI-1 secreted by the adipocytes derived from a gram of adipose tissue is 144%, 75%, 72%, 37%, and 23%, respectively, of that by the nonfat cells derived from the same amount of human adipose tissue. However, the release of IL-8, MCP-1, vascular endothelial growth factor (VEGF), TGF-beta 1, IL-6, PGE(2), TNF-alpha, cathepsin S, hepatocyte growth factor (HGF), ILA-1 beta, IL-10, resistin, C-reactive protein (CRP), and interleukin-1 receptor antagonist (IL-1Ra) by adipocytes is less than 12% of that by the nonfat cells present in human adipose tissue. Obesity markedly elevates the total release of TNF-a, IL-6, and IL-8 by adipose tissue but only that of TNF-a is enhanced in adipocytes. However, on a quantitative basis the vast majority of the TNF-alpha comes from the nonfat cells. Visceral adipose tissue also releases more VEGF, resistin, IL-6, PAI-1, TGF-beta 1, IL-8, and IL-10 per gram of tissue than does abdominal subcutaneous adipose tissue. In conclusion, there is an increasing recognition that adipose tissue is an endocrine organ that secretes leptin and adiponectin along with a host of other paracrine and endocrine factors in addition to free fatty acids. (c) 2006 Elsevier Inc.
引用
收藏
页码:443 / 477
页数:35
相关论文
共 142 条
  • [1] Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity
    Alessi, MC
    Bastelica, D
    Morange, P
    Berthet, B
    Leduc, I
    Verdier, M
    Geel, O
    Juhan-Vague, I
    [J]. DIABETES, 2000, 49 (08) : 1374 - 1380
  • [2] Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease
    Alessi, MC
    Peiretti, F
    Morange, P
    Henry, M
    Nalbone, G
    JuhanVague, I
    [J]. DIABETES, 1997, 46 (05) : 860 - 867
  • [3] Bastard JP, 1999, CIRCULATION, V99, P2221
  • [4] Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro
    Bastard, JP
    Maachi, M
    Van Nhieu, JT
    Jardel, C
    Bruckert, E
    Grimaldi, A
    Robert, JJ
    Capeau, J
    Hainque, B
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) : 2084 - 2089
  • [5] Bastelica D, 2002, THROMB HAEMOSTASIS, V88, P481
  • [6] Monocyte cyclooxygenase-2 overactivity:: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?
    Beloqui, O
    Páramo, JA
    Orbe, J
    Benito, A
    Colina, I
    Monasterio, A
    Díez, J
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (02) : 153 - 158
  • [7] Adipose tissue, inflammation, and cardiovascular disease
    Berg, AH
    Scherer, PE
    [J]. CIRCULATION RESEARCH, 2005, 96 (09) : 939 - 949
  • [8] Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina
    Blankenberg, S
    Tiret, L
    Bickel, C
    Peetz, D
    Cambien, F
    Meyer, J
    Rupprecht, HJ
    [J]. CIRCULATION, 2002, 106 (01) : 24 - 30
  • [9] IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women - The EPIC-Norfolk prospective population study
    Boekholdt, SM
    Peters, RJG
    Hack, CE
    Day, NE
    Luben, R
    Bingham, SA
    Wareham, NJ
    Reitsma, PH
    Khaw, KT
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) : 1503 - 1508
  • [10] Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro
    Bruun, JM
    Pedersen, SB
    Richelsen, B
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) : 1267 - 1273